The Agency for Healthcare Research and Quality is looking more closely at why some patients diagnosed with depression don't respond to treatment. Currently, there is scant data on the prevalence of...
Diagnosing diseases is a tricky business requiring a formidable breadth and depth of knowledge and the skill to apply it. The rarer the disease is, the harder it can be to diagnose: quality reference...
Mark your calendars for the event of the year: OHSU Research Week. Our annual celebration of research performed by faculty, students, research staff, postdocs, and others across all schools, centers,...
Glial cells, once considered passive bystanders of neural transmission, are now understood to provide support and protection for neurons in the central and peripheral nervous systems. Astrocytes,...
The Clinical and Translational Research Center now offers OHSU investigators access to a Research Volunteer Registry of subjects interested in participating in research projects. The registry also...
Do you have an innovative idea for a drug discovery project? AstraZeneca is seeking opportunities to work with like-minded scientists in academia and organizations with the common goal of...
Programmed cell death 1 (PD-1) inhibitors have shown anti-tumor activity in patients with melanoma, renal cell, non-small cell lung cancer, and bladder cancer. However, patients with...
Diabetes affects nearly 30 million people in the United States. The disease is caused by dysfunction or loss of insulin-producing beta cells that normalize blood sugar levels in the body. Until now,...
Marvin Yingbin Ouyang, Ph.D., vice president of technology at Cyagen Biosciences, Inc., will present "CRISPR/Cas9 and TurboKnockout: Technologies for rapid generation of knockout/knockin mouse...
Join Bob Searles, Massively Parallel Sequencing Shared Resource, and Chris Harrington, Gene Profiling/RNA and DNA Services Shared Resources, who will discuss new genomics technologies available in...